104 related articles for article (PubMed ID: 11060477)
1. An open study with acamprosate in Belgium and Luxemburg: results on sociodemographics, supportive treatment and outcome.
Ansoms C; Deckers F; Lehert P; Pelc I; Potgieter A
Eur Addict Res; 2000 Sep; 6(3):132-40. PubMed ID: 11060477
[TBL] [Abstract][Full Text] [Related]
2. [Acamprosate and psychosocial intervention. An integrative treatment approach for prevention of alcohol dependent patients in Switzerland].
Fuchs WJ; Riebenfeld D
Praxis (Bern 1994); 2002 Apr; 91(17):735-42. PubMed ID: 12038194
[TBL] [Abstract][Full Text] [Related]
3. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
Soyka M; Preuss U; Schuetz C
Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
[TBL] [Abstract][Full Text] [Related]
4. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
[TBL] [Abstract][Full Text] [Related]
5. Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?
De Wildt WA; Schippers GM; Van Den Brink W; Potgieter AS; Deckers F; Bets D
Alcohol Alcohol; 2002; 37(4):375-82. PubMed ID: 12107041
[TBL] [Abstract][Full Text] [Related]
6. Acamprosate in alcohol dependence: how does it work?
Littleton J
Addiction; 1995 Sep; 90(9):1179-88. PubMed ID: 7580816
[TBL] [Abstract][Full Text] [Related]
7. Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.
Zarkin GA; Bray JW; Aldridge A; Mitra D; Mills MJ; Couper DJ; Cisler RA;
Arch Gen Psychiatry; 2008 Oct; 65(10):1214-21. PubMed ID: 18838638
[TBL] [Abstract][Full Text] [Related]
8. An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence.
de Sousa A; de Sousa A
Alcohol Alcohol; 2005; 40(6):545-8. PubMed ID: 16043433
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of recurrent alcoholism with acamprosate. Neurobiological principles and clinical results].
Soyka M; Zieglgänsberger W
Internist (Berl); 1999 Mar; 40(3):330-6. PubMed ID: 10205765
[No Abstract] [Full Text] [Related]
10. Does acamprosate improve reduction of drinking as well as aiding abstinence?
Chick J; Lehert P; Landron F;
J Psychopharmacol; 2003 Dec; 17(4):397-402. PubMed ID: 14870951
[TBL] [Abstract][Full Text] [Related]
11. Effect of community nurse follow-up when treating alcohol dependence with acamprosate.
Pelc I; Hanak C; Baert I; Houtain C; Lehert P; Landron F; Verbanck P
Alcohol Alcohol; 2005; 40(4):302-7. PubMed ID: 15870092
[TBL] [Abstract][Full Text] [Related]
12. Acamprosate.
Mason BJ
Recent Dev Alcohol; 2003; 16():203-15. PubMed ID: 12638639
[No Abstract] [Full Text] [Related]
13. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
[TBL] [Abstract][Full Text] [Related]
14. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
[TBL] [Abstract][Full Text] [Related]
15. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.
Verheul R; Lehert P; Geerlings PJ; Koeter MW; van den Brink W
Psychopharmacology (Berl); 2005 Mar; 178(2-3):167-73. PubMed ID: 15322728
[TBL] [Abstract][Full Text] [Related]
16. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
[TBL] [Abstract][Full Text] [Related]
17. [Alcoholism: relapse prevention].
Pelc I
Rev Med Brux; 1997 Sep; 18(4):272-6. PubMed ID: 9411660
[TBL] [Abstract][Full Text] [Related]
18. Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone.
Kiefer F; Jiménez-Arriero MA; Klein O; Diehl A; Rubio G
Addict Biol; 2008 Mar; 13(1):124-9. PubMed ID: 17573782
[TBL] [Abstract][Full Text] [Related]
19. The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.
Wölwer W; Frommann N; Jänner M; Franke PE; Scherbaum N; Lieb B; Falkai P; Wobrock T; Kuhlmann T; Radermacher M; Maier W; Schütz C; Ohmann C; Burtscheidt W; Gaebel W
Drug Alcohol Depend; 2011 Nov; 118(2-3):417-22. PubMed ID: 21621929
[TBL] [Abstract][Full Text] [Related]
20. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
Rösner S; Leucht S; Lehert P; Soyka M
J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
